Rolfes, L.; Pawlitzki, M.; Pfeuffer, S.; Thomas, C.; Schmidt-Chanasit, J.; Gross, C.C.; Schulte-Mecklenbeck, A.; Wiendl, H.; Meuth, S.G.; M. Grauer, O.;
et al. Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination. Int. J. Mol. Sci. 2019, 20, 5985.
https://doi.org/10.3390/ijms20235985
AMA Style
Rolfes L, Pawlitzki M, Pfeuffer S, Thomas C, Schmidt-Chanasit J, Gross CC, Schulte-Mecklenbeck A, Wiendl H, Meuth SG, M. Grauer O,
et al. Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination. International Journal of Molecular Sciences. 2019; 20(23):5985.
https://doi.org/10.3390/ijms20235985
Chicago/Turabian Style
Rolfes, Leoni, Marc Pawlitzki, Steffen Pfeuffer, Christian Thomas, Jonas Schmidt-Chanasit, Catharina C. Gross, Andreas Schulte-Mecklenbeck, Heinz Wiendl, Sven G. Meuth, Oliver M. Grauer,
and et al. 2019. "Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination" International Journal of Molecular Sciences 20, no. 23: 5985.
https://doi.org/10.3390/ijms20235985
APA Style
Rolfes, L., Pawlitzki, M., Pfeuffer, S., Thomas, C., Schmidt-Chanasit, J., Gross, C. C., Schulte-Mecklenbeck, A., Wiendl, H., Meuth, S. G., M. Grauer, O., & Ruck, T.
(2019). Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination. International Journal of Molecular Sciences, 20(23), 5985.
https://doi.org/10.3390/ijms20235985
